LTS Lohmann Therapie-Systeme AG

About LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG is a trusted partner in the pharmaceutical industry, specializing in innovative oral, transdermal, and intradermal drug delivery systems. From concept to market and lifecycle management, LTS delivers single-source solutions to enhance partners' market advantage and improve patient outcomes. With over 1,000 team members across three continents, LTS focuses on innovation, partner value, and therapeutic advancements through non-invasive delivery technologies.

Products & Services

Transdermal Therapeutic Systems (TTS):Technologies utilized in multiple active substances for safe, reliable, precise, and convenient application for patients.

Oral Thin Films (OTF):Used in a wide range of applications, offering clear advantages for fast delivery to partners and patients.

Micro Array Patches (MAP):Dissolvable microneedle technology delivering faster onset, enhanced compliance, and reduced healthcare costs.

On-Body Delivery Systems (OBDS):Designed to deliver large volume and highly viscous formulations at home.

Topical Patch Systems (TOPS):Powerful topical patches for fast pain relief and maximum comfort.

Specialties

Non-invasive drug delivery Transdermal therapeutic systems Oral thin film technologies Microneedle technology On-body delivery systems Topical patch systems Research and Development Process Development Manufacturing Contract Development and Manufacturing (CDMO) In vitro permeation studies (Skin Lab)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 4300000 MR: - FA: $4.3 million FAN: 4300000	D: 2023-12-19 FD: 2023-12-19	1 investors
2	RT: Grant T: - FT: Grant	A: 1200000 MR: - FA: $1.2 Million FAN: 1200000	D: 2023-12-06 FD: 2023-12-06	1 investors

Grant Latest

2023-12-19

$4.3M

1 investor (Pro only)

Grant 2023-12-06

$1.2M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Sebastiaan M. van Buijtenen

Chairman of the Executive Board

U

Ulrich Sielaff

Chief Financial Officer

D

Dr. Claudia Schaefer

Chief Operating Officer

D

Dr. Detlev Radloff

President LTS EMEA/A

D

Dave Doles

President LTS North America

D

Dr. Andrei Yosef

President and General Manager Device Technologies

View 12 more team members with Pro

Unlock Full Team Directory

Recent News